U.S. Chemicals Stock News

Interest in Nextpower (NXT) has picked up after a recent stock pullback and ahead of its upcoming earnings report. Quarterly figures are expected to decline even as full year revenue and earnings estimates imply growth. See our latest analysis for Nextpower. At a share price of $114.27, Nextpower has seen a 1 day share price decline of 1.95% and a 7 day share price decline of 8.11%. However, its year to date share price return of 23.16% and very large 1 year total shareholder return of...

Baker Hughes reported past first-quarter 2026 results with sales of US$6,587 million and net income of US$930 million, alongside a US$0.23 quarterly dividend declaration. The company’s strong earnings and new LNG equipment award for Qatar’s North Field project underscore its role in critical global energy infrastructure despite regional disruptions. We’ll now examine how Baker Hughes’ resilient Q1 performance and Qatar LNG contract reshape its investment narrative and risk profile. The...

NXP Semiconductors N.V. recently reported first-quarter 2026 results, with sales rising to US$3.18 billion and net income reaching US$1.12 billion, alongside earnings per share more than doubling year on year. Management’s outlook for the second quarter, including revenue guidance of US$3.35 billion to US$3.55 billion driven by automotive and industrial demand, reinforces the company’s emphasis on software-defined vehicles and “physical AI” at the edge. With this stronger-than-expected...

In recent weeks, Lucid Group has faced management changes, capital-raising moves, and growing speculation about going private, while also preparing to report its latest earnings on 5 May 2026. At the same time, Uber’s US$500 million investment and agreement to purchase at least 35,000 Lucid vehicles highlight a potential pivot toward higher-margin autonomous software and fleet partnerships. We’ll now examine how Uber’s planned investment and vehicle purchase agreement could reshape Lucid...

SL Green Realty (SLG) continues to attract attention as investors assess its recent share performance, with the stock up about 18.2% over the past month but down over the past three months. See our latest analysis for SL Green Realty. The recent 18.2% one-month share price return contrasts with a 4.8% decline over three months and a 9.7% year-to-date drop. The three-year total shareholder return of about 137% highlights how sentiment around income and price gains has shifted over time. If you...

Why Medical Properties Trust is drawing attention now Medical Properties Trust (MPT) is back on investor radars after recent share price moves, with the stock closing at US$5.13 and showing mixed returns over the past year. With a market value of about US$3.1b and operations spanning 388 hospital facilities across nine countries, the trust offers exposure to a large, specialized health care real estate portfolio. See our latest analysis for Medical Properties Trust. The recent pullback in the...

Dividend increase and buybacks put Hess Midstream in focus Hess Midstream (HESM) raised its quarterly cash distribution to US$0.7792 per Class A share for the first quarter of 2026, supported by recent share repurchases and described as exceeding its stated distribution growth target. See our latest analysis for Hess Midstream. The dividend increase comes as the share price trades at US$38.32, with a 10.59% year to date share price return and a 148.00% total shareholder return over five...

Equity Residential (EQR) opened 2026 with Q1 funds from operations of US$340.9 million, or FFO per share of US$0.89, on total revenue of US$779.8 million and basic EPS of US$0.24, setting the tone for how income investors will read the latest report. Over recent periods, total revenue has moved from US$760.8 million in Q1 2025 to US$779.8 million in Q1 2026. Trailing twelve month basic EPS sits at US$2.51 on revenue of about US$3.1 billion, providing a clearer sense of the scale of the...

With Becton Dickinson trading at US$145.31, many investors are asking a simple question: is the current price giving fair value for a global medical equipment leader, or has the market moved too far in one direction? Recent returns, including a 6.6% decline over the last 7 days, 6.1% over 30 days, 25.5% year to date and 8.6% over the past year, suggest sentiment around the stock has shifted and may be influencing how the market is thinking about risk and opportunity. While there has not been...

American International Group (NYSE:AIG) has completed its CEO succession plan. Eric Andersen will become President and CEO, effective June 1. Current CEO Peter Zaffino will transition to the role of Executive Chair. Andersen will also join AIG's board of directors as part of the transition. AIG is a large global insurer with operations across commercial and consumer insurance, as well as related financial services. For a company of this scale, a finalized leadership handover is a key...

Wondering if Teledyne Technologies at around US$630 per share is priced for opportunity or already reflects the story you see? The next sections will help you size up the value behind the ticker. The stock has been volatile recently, with a 4.0% decline over the last 7 days, an 8.0% return over 30 days and returns of 21.5% year to date, 35.3% over 1 year, 53.4% over 3 years and 46.9% over 5 years. Recent market attention on Teledyne has centered on its role as a diversified technology...

If you are wondering whether Melco Resorts & Entertainment at around US$5.50 is a bargain or a value trap, this breakdown will help you frame the trade off between price and underlying business value. The stock has seen a 8.2% decline over the last week, is down 1.1% over 30 days and 26.8% year to date, yet still shows a 6.8% return over the past year alongside much larger 3 year and 5 year declines of 57.3% and 70.3% respectively. Recent market attention has focused on how Melco fits into...

Earlier this month, Cookeville Regional Medical Center and Encompass Health announced plans to build a freestanding, 40-bed inpatient rehabilitation hospital on Cookeville Regional’s campus in Tennessee, expanding services for patients recovering from strokes, neurological conditions, and complex injuries and integrating advanced therapy facilities and technologies. The alliance not only deepens Encompass Health’s presence in Tennessee but also converts and scales an existing 20-bed unit...

Tradr has launched the 2X Short Lumentum ETF, a leveraged product designed to give traders amplified inverse exposure to Lumentum Holdings. The ETF focuses specifically on NasdaqGS:LITE, underscoring the company's role in AI focused optics and data center infrastructure. Lumentum Holdings, listed as NasdaqGS:LITE, currently sits at a share price of $858.32, with recent returns that are drawing attention. The stock is up 22.1% over the past 30 days and 122.3% year to date, while the very...

What Figure Technology Solutions stock’s recent moves tell you Figure Technology Solutions (FIGR) has been catching attention after a mixed run, with a 3.2% decline in the last day, a 6.7% drop over the past week, and an 8.3% gain over the month. See our latest analysis for Figure Technology Solutions. At a share price of $33.27, Figure Technology Solutions has a 30 day share price return of 8.3%. However, the 90 day share price return of a 45.0% decline points to fading momentum after...

Cognex Corporation recently launched the In-Sight 6900 Vision Controller, a modular, NVIDIA Jetson-powered edge AI system that lets manufacturers tailor cameras, optics, and lighting for demanding inspection tasks without external PCs or complex architectures. A particularly interesting aspect is its few-sample, transformer-based classification and robust segmentation, which aims to handle highly variable defects and dynamic production conditions while integrating tightly with Cognex’s...

Graco (NYSE:GGG) is marking its 100th anniversary with a global land art installation created in collaboration with artist Saype. The project uses Graco equipment to produce large scale, temporary artworks across multiple international locations. The anniversary initiative underscores Graco's global reach and the use of its technology in a high profile cultural setting. Graco, trading at $79.57, is using its centennial year to spotlight the brand in a way that goes beyond typical product or...

FS Bancorp (FXLG) prints steady Q1 2026 numbers FS Bancorp (FXLG) has opened 2026 with Q1 results that show total revenue of US$13.31 million and basic EPS of US$1.35, setting the tone against a backdrop of rising trailing twelve month earnings. The company has seen revenue move from US$11.68 million in Q1 2025 to US$13.31 million in Q1 2026, while basic EPS stepped from US$1.12 to US$1.35 over the same period, as trailing EPS reached US$5.20 on net income of US$21.46 million across the last...

Despite announcing strong earnings, CBRE Group, Inc.'s ( NYSE:CBRE ) stock was sluggish. Our analysis uncovered some...

Tractor Supply (NasdaqGS:TSCO) has partnered with ITG and adopted Storyteq technology to automate and scale its marketing workflows. The company reports a 32% reduction in email marketing costs, with content production becoming more efficient without adding budget or headcount. This operational shift supports Tractor Supply's customer engagement efforts as it expands its footprint and marketing reach. Tractor Supply, trading at $34.77, has seen pressure on its share price, with a 23.2%...

In late April 2026, Centene Corporation reported first-quarter revenue of US$49.94 billion and net income of US$1.54 billion, with both basic and diluted EPS from continuing operations rising year on year. Alongside these results, Centene raised its 2026 earnings guidance, highlighting stronger-than-expected margins in its Medicaid and Medicare businesses while working to reprice its challenged Marketplace segment. We’ll now examine how Centene’s upgraded 2026 earnings outlook, driven by...

Last week, you might have seen that Armstrong World Industries, Inc. ( NYSE:AWI ) released its first-quarter result to...

EMCOR Group (EME) heads into its Q1 2026 reporting cycle coming off a strong finish to 2025, with Q4 revenue of US$4.5b and basic EPS of US$9.72, alongside trailing twelve month revenue of US$17.0b and EPS of US$28.30. Over the past six quarters, the company has seen revenue move from US$3.7b in Q3 2024 to US$4.5b in Q4 2025, while basic EPS over that span has ranged between US$5.27 and US$9.72, supported by a trailing net profit margin of 7.5% compared with 6.9% a year earlier. That...

In recent days, attention on CRISPR Therapeutics has intensified ahead of its March-quarter earnings report, as analysts expect higher revenue and earnings alongside evolving estimates. Investor focus is also being shaped by rising sales of Casgevy, the gene-editing therapy co-developed with Vertex Pharmaceuticals, which is showing sequential launch momentum. We’ll now examine how expectations for stronger quarterly results and early Casgevy uptake could influence CRISPR Therapeutics’...